Metabolic dysfunction-associated steatotic liver disease (MASLD), nonalcoholic fatty liver disease (NAFLD), and fatty liver disease all describe conditions where too much fat builds up in the liver, ...

Fatty liver disease, including non‑alcoholic fatty liver disease (NAFLD) or metabolic dysfunction‑associated steatotic liver disease (MASLD), occurs when fat accumulates in liver cells, often without ...

Fatty liver disease, including MASLD, is a global health issue. It impacts overall health, especially the heart. Individuals with fatty liver face higher risk of atherosclerosis and heart failure.

Metabolic dysfunction-associated steatohepatitis (MASH) starts in your liver, but it can have body-wide effects. These effects increase your risk of conditions like heart disease, chronic kidney ...

Metabolic dysfunction-associated steatohepatitis (MASH), formally known as nonalcoholic steatohepatitis (NASH), is a liver disease that develops when accumulated liver fat causes inflammation and ...

MASH is the new term for NASH. MASH stands for metabolic dysfunction–associated steatohepatitis, a type of liver disease. The liver disease used to be referred to as non-alcoholic steatohepatitis, or ...

Fatty liver disease is a health condition in which fat builds up in the liver. This fat buildup can cause inflammation and, in severe cases, liver damage. There are two main types of fatty liver ...

“If you have or are at risk for MASLD, the most important thing you can do is lose weight. Weight loss can help reduce liver fat, decrease inflammation, and potentially reverse liver scarring. Even ...

Fatty liver disease affects nearly 40% of the global population, with significant links to metabolic dysfunction and severe health consequences. Despite its prevalence, fatty liver disease remains ...